₩11,080-0.63%
2026-10-06 closeGemVax&KAEL's published financial data is dated 2026-10-04. 2024 revenue was KRW 62.69B. 2024 operating profit was −KRW 38.68B.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy
GemVax&KAEL's published financial data is dated 2026-10-04. 2024 revenue was KRW 62.69B. 2024 operating profit was −KRW 38.68B.